A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
Introduction: Ovarian cancer is one of the most lethal gynecologic cancers. Relapses after remission are common, hence novel strategies are urgently needed. Our group has previously developed a vaccination approach based on dendritic cells pulsed with HOCl-oxidized tumor lysates. Here we investigate...
Main Authors: | Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2018-05-01
|
Series: | BioImpacts |
Subjects: | |
Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-8-211.pdf |
Similar Items
-
IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine
by: Ananda Mookerjee, et al.
Published: (2019-01-01) -
Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
by: Ananda Mookerjee, et al.
Published: (2019-01-01) -
Examining the Impact of Squaric Acid as a Crosslinking Agent on the Properties of Chitosan-Based Films
by: Ewa Olewnik-Kruszkowska, et al.
Published: (2021-03-01) -
GM-CSF Stress-Induced Priming of the Dendritic Cell
by: Grant, Olivia M.
Published: (2015) -
Chitosan–Collagen Coated Magnetic Nanoparticles for Lipase Immobilization—New Type of “Enzyme Friendly” Polymer Shell Crosslinking with Squaric Acid
by: Marta Ziegler-Borowska, et al.
Published: (2017-01-01)